Gender-related factors in medication adherence for metabolic and cardiovascular health
V Venditti, E Bleve, S Morano, T Filardi - Metabolites, 2023 - mdpi.com
This review explores the impact of gender on medication adherence in the context of
metabolic and cardiovascular diseases. Optimal adherence to medication is crucial for …
metabolic and cardiovascular diseases. Optimal adherence to medication is crucial for …
Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
NR Desai, M Farbaniec, DG Karalis - Clinical Cardiology, 2023 - Wiley Online Library
Despite the availability of effective therapies that lower low‐density lipoprotein cholesterol
(LDL‐C) levels in patients with atherosclerotic cardiovascular disease, many eligible …
(LDL‐C) levels in patients with atherosclerotic cardiovascular disease, many eligible …
Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France
Aims The role of statin therapy in primary prevention of cardiovascular disease in persons
older than 75 years remains a subject of debate with little evidence to support or exclude the …
older than 75 years remains a subject of debate with little evidence to support or exclude the …
Reasons for nonadherence to statins–a systematic review of reviews
MV Ingersgaard, T Helms Andersen… - Patient preference …, 2020 - Taylor & Francis
Purpose Lipid-lowering medications are often prescribed to decrease the risk of micro-and
macro-cardiovascular complications related to dyslipidaemia. Despite widespread …
macro-cardiovascular complications related to dyslipidaemia. Despite widespread …
Role of statin therapy in primary prevention of cardiovascular disease in elderly patients
TE Strandberg - Current atherosclerosis reports, 2019 - Springer
Abstract Purpose of Review Hypercholesterolemia and statin treatment are nowadays
common among people older than 75 years, but clinical heterogeneity in this increasing age …
common among people older than 75 years, but clinical heterogeneity in this increasing age …
Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial …
M Wawruch, M Petrova, T Tesar, J Murin… - Frontiers in …, 2023 - frontiersin.org
Introduction: As in other chronic conditions, medication adherence is important in the
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
treatment of peripheral arterial disease (PAD). Our study aimed at a) analysing non …
Predictors of first‐year nonadherence and discontinuation of statins among older adults: a retrospective cohort study
Aims The aim of this study was to examine the level of and predictors of statin nonadherence
and discontinuation among older adults. Methods Among 22 340 Australians aged≥ 65 …
and discontinuation among older adults. Methods Among 22 340 Australians aged≥ 65 …
Interpersonal communication-, education-and counselling-based interventions to support adherence to oral anticancer therapy: a systematic review
J Elston Lafata, B Nguyen… - Journal of Oncology …, 2023 - journals.sagepub.com
Background. Many factors contribute to oral anti-cancer therapy adherence, including
counselling and educational support. Objective. We systematically review the literature …
counselling and educational support. Objective. We systematically review the literature …
Interventions to improve adherence to cardiovascular medication: what about gender differences? A systematic literature review
M Vervloet, JC Korevaar, CJ Leemrijse… - Patient preference …, 2020 - Taylor & Francis
Background Compared to men, women have lower treatment rates for cardiovascular
disease (CVD), are at higher risk for medication non-adherence and have different reasons …
disease (CVD), are at higher risk for medication non-adherence and have different reasons …
Statin use and safety concerns: an overview of the past, present, and the future
Introduction Dyslipidemia is a significant risk factor for cardiovascular disorders and
contributes to significant morbidity and mortality associated with CAD and stroke worldwide …
contributes to significant morbidity and mortality associated with CAD and stroke worldwide …